Press Releases

 
Press Releases
Date Title and Summary View
08/08/2014 TEANECK, N.J., Aug. 8, 2014 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (Nasdaq:PAHC) will host a webcast and conference call to review fourth quarter and fiscal year 2014 financial results, discuss fiscal year 2015 financial guidance and respond to questions from investors. A news release containing quarterly and fiscal year results is ex...
07/28/2014 TEANECK, N.J., July 28, 2014 (GLOBE NEWSWIRE) -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC), today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on September 24, 2014, to stockholders of record at the close of business on September 3, 2014.About Phib...
06/02/2014 OSLO, Norway and TEANECK, N.J., June 2, 2014 (GLOBE NEWSWIRE) -- The Norwegian vaccine company Vaccibody and Phibro Animal Health Corporation (Nasdaq:PAHC), a global animal health and mineral nutrition company, have signed a global exclusive license agreement which grants Phibro and its affiliates the right to develop, market and sell novel vaccine...
05/14/2014 TEANECK, N.J., May 14, 2014 (GLOBE NEWSWIRE) -- In the release dated May 13, 2014 by Phibro Animal Health Corporation (Nasdaq:PAHC), the last clause of the first sentence of the first paragraph under "FINANCIAL GUIDANCE" should read, "and pro forma adjusted diluted EPS will be approximately $0.19 to $0.21" (instead of "$0.21 to $0.24"). The cor...
05/02/2014 TEANECK, N.J., May 2, 2014 (GLOBE NEWSWIRE) -- (Nasdaq:PAHC)--Phibro Animal Health Corporation will host a webcast and conference call to review third quarter fiscal 2014 financial results. A news release containing quarterly results is expected to be issued after the market closes on May 13, 2014. Details for the public webcast are as follows:...
04/11/2014 Teaneck, New Jersey, April 11, 2014 – Phibro Animal Health Corporation (Nasdaq:PAHC) (the “Company”) today announced the pricing of its initial public offering of 12,745,392 shares of Class A Common Stock (“Class A Common Stock”) at a price to the public of $15.00 per share.  The shares ar...
03/31/2014 Teaneck, New Jersey, March 31, 2014 – Phibro Animal Health Corporation (the “Company”) today announced that it has commenced an initial public offering of 11,765,000 shares of its Class A Common Stock (“Class A Common Stock”) pursuant to a registration statement on Form S-1 filed with the Securi...
03/10/2014 Teaneck, New Jersey, March 10, 2014 – Phibro Animal Health Corporation (“Phibro” or “the Company”) announced today that it has publicly filed a registration statement on Form S-1 with the Securities and Exchange Commission (the “Commission”) relating to a proposed initial public of...
01/20/2014 Teaneck, NJ – January 20, 2014 Phibro Animal Health Corporation announced today that it has acquired the aquaculture assets of AquaVet Ltd., a technical consulting and contract research organization focused on the global aquaculture market. Dr. Ra’anan Ariav, D.V.M. and founder and CEO of AquaVet, will join Phibr...
11/19/2013 Teaneck, NJ and Willmar, MN – November 19, 2013 Phibro Animal Health Corporation and Epitopix have entered into a partnership to manufacture and market biological products for chickens in the United States based on Epitopix’s novel SRP® technology. Additionally, the parties intend to collaborate on a global basis to ...
Page: FirstPrevious ...
6
= add release to Briefcase

© 2009 - 2017 Phibro Animal Health Corporation. All rights reserved.

Privacy Policy • Terms of Use